Exploring how glioblastoma organoids (GBOs) are revolutionizing personalized brain cancer therapy through 3D tissue models that mimic patient tumors.
Discover how CRISPR-edited organoids are revolutionizing cancer research by decoding mutational signatures and revealing cancer origins.